InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the full record of transactions filed by Lettmann Jason, Director. Director active across 1 company, notably ALX Oncology Holdings INC. Aggregated, 4 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €2.6m. Activity tracked since 8 December 2021. The latest transaction was disclosed on 13 December 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
11,945 shares@ US$25.290.098% mcap20.2% of flowCommon StockSEC:0000899243-21-048463
11,945 shares@ US$25.290.098% mcap10.1% of flowCommon StockSEC:0000899243-21-048463:0
35,836 shares@ US$33.230.39% mcap39.9% of flowCommon StockSEC:0001209191-21-069154:0
35,836 shares@ US$33.230.39% mcap79.8% of flowCommon StockSEC:0001209191-21-069154
4 of 4 declarations
About Lettmann Jason
Jason Lettmann is a Board Member at ALX Oncology Holdings Inc. He plays a key role in the company's governance, contributing to strategy and decision-making. His experience is valuable for the development of ALX Oncology.
